Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Major

Showing results (161-170 of 189) with videos related to

Pageof 19
Sort By:
Plos One|March 10, 2022
Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan ChicagoEric Tatara, Alexander Gutfraind, Nicholson T Collier, et al.
Vaccine|May 12, 2009
T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutationI Zubkova, Y H Choi, E Chang, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|February 17, 2024
The genome of a globally invasive passerine, the common myna, Acridotheres tristisKatarina C Stuart, Rebecca N Johnson, Richard E Major, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2004
Neutralizing antibody response during acute and chronic hepatitis C virus infectionC Logvinoff, M E Major, D Oldach, et al.
Anaesthesia|December 1, 1984
Dose requirements of ICI 35,868 (propofol, 'Diprivan') in a new formulation for induction of anaesthesiaG C Cummings, J Dixon, N H Kay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"J Havla, A Berthele, T Kümpfel, et al.
Molecular Pharmaceutics|October 25, 2013
Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNAAlla Kachko, Sandra Loesgen, Syed Shahzad-Ul-Hussan, et al.
JMIR Rehabilitation and Assistive Technologies|February 22, 2023
Telerehabilitation Delivery in Canada and the Netherlands: Results of a Survey StudyEdward Giesbrecht, Mel E Major, Moni Fricke, et al.
Plos One|March 24, 2023
Recommendations for an exercise intervention and core outcome set for older patients after hospital discharge: Results of an international Delphi studyJesse J Aarden, Mel E Major, Claartje M W Aghina, et al.
Virology|November 24, 1999
Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptorsF Sabri, E Tresoldi, M Di Stefano, et al.
Pageof 19

Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Plos One|March 10, 2022
Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan ChicagoEric Tatara, Alexander Gutfraind, Nicholson T Collier, et al.
Vaccine|May 12, 2009
T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutationI Zubkova, Y H Choi, E Chang, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|February 17, 2024
The genome of a globally invasive passerine, the common myna, Acridotheres tristisKatarina C Stuart, Rebecca N Johnson, Richard E Major, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2004
Neutralizing antibody response during acute and chronic hepatitis C virus infectionC Logvinoff, M E Major, D Oldach, et al.
Anaesthesia|December 1, 1984
Dose requirements of ICI 35,868 (propofol, 'Diprivan') in a new formulation for induction of anaesthesiaG C Cummings, J Dixon, N H Kay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"J Havla, A Berthele, T Kümpfel, et al.
Molecular Pharmaceutics|October 25, 2013
Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNAAlla Kachko, Sandra Loesgen, Syed Shahzad-Ul-Hussan, et al.
JMIR Rehabilitation and Assistive Technologies|February 22, 2023
Telerehabilitation Delivery in Canada and the Netherlands: Results of a Survey StudyEdward Giesbrecht, Mel E Major, Moni Fricke, et al.
Plos One|March 24, 2023
Recommendations for an exercise intervention and core outcome set for older patients after hospital discharge: Results of an international Delphi studyJesse J Aarden, Mel E Major, Claartje M W Aghina, et al.
Virology|November 24, 1999
Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptorsF Sabri, E Tresoldi, M Di Stefano, et al.
Pageof 19